PHARMACEUTICAL INDUSTRY SYMPOSIUM 3 BY ROCHE
LUNSUMIO changes the patients outcomes in relapse or refractory follicular lymphoma
Moderator: Prof. Irina Panovska-Stavridis
|
|
Challenges in the third-line treatment of FL |
Prof. d-r Zlate Stojanoski University Clinic of Hematology, Skopje |
|
|
Profile of Macedonian patients eligible for third line treatment with Lunsumio |
Prof. d-r Irina Panovska Stavridis University Clinic of Hematology, Skopje |
|
|
Lunsumio, new treatment option in relapsed or refractory follicular lymphoma |
Prof. d-r Francesc Bosch, Head of Hematology Unit, Vall d’Hebron Hospital, Autonomous University, Barcelona, Spain |
|
|
Panel discussion: How to improve the treatment outcomes of FL patients? |
Panelists: |
